CSIMarket


Navidea Biopharmaceuticals Inc   (NAVB)
Other Ticker:  
 

Navidea Biopharmaceuticals Inc

NAVB's Fundamental analysis








Navidea Biopharmaceuticals Inc 's sales fell in III. Quarter 2023 from the same quarter a year ago.

In Vitro & In Vivo Diagnostic Substances industry recorded growth of revenues by 11.11 %

Navidea Biopharmaceuticals Inc net loss deacreased by in III. Quarter 2023 year on year, Navidea Biopharmaceuticals Inc net loss increased by -60.49 % in III. Quarter 2023 year on year,

More on NAVB's Growth


Navidea Biopharmaceuticals Inc
realized net loss in trailing twelve months.

Navidea Biopharmaceuticals Inc realized cash outflow of $ -0per share in trailing twelve-month period.
In Vitro & In Vivo Diagnostic Substances industry recorded net loss in trailing twelve months.
Company
-0
PE TTM   
Industry
-
PE TTM    
Company's Price to Sales ratio is at 16.29.
In Vitro & In Vivo Diagnostic Substances industry's Price to Sales ratio is at 8.55.


More on NAVB's Valuation
 
 Total Debt (Millions $) -
 Dividend TTM ($) 0 $
 Dividend Yield TTM (%) -
 Revenue/Employee (TTM) $ -
 Net Income/Employee (TTM) $ -
 Receivable Turnover (TTM) -
 Tangible Book Value (Per Share $) -0.04

Navidea Biopharmaceuticals Inc
realized net loss in trailing twelve months.

Navidea Biopharmaceuticals Inc realized cash outflow of $ -0per share in trailing twelve-month period.
In Vitro & In Vivo Diagnostic Substances industry recorded net loss in trailing twelve months.
Company
-0
PE TTM   
Industry
-
PE TTM    
Company's Price to Sales ratio is at 16.29.
In Vitro & In Vivo Diagnostic Substances industry's Price to Sales ratio is at 8.55.


More on NAVB's Valuation

  Market Capitalization (Millions $) 0
  Shares Outstanding (Millions) 99
  Employees -
  Revenues (TTM) (Millions $) -
  Net Income (TTM) (Millions $) -1
  Cash Flow (TTM) (Millions $) 0
  Capital Exp. (TTM) (Millions $) -1
  Total Debt (Millions $) -
  Dividend TTM ($) 0 $
  Dividend Yield TTM (%) -
  Revenue/Employee (TTM) $ -
  Net Income/Employee(TTM) $ -
  Receivable Turnover Ratio (TTM) -
  Tangible Book Value (Per Share $) -0.04

  Market Capitalization (Millions $) 0
  Shares Outstanding (Millions) 99
  Employees -
  Revenues (TTM) (Millions $) -
  Net Income (TTM) (Millions $) -1
  Cash Flow (TTM) (Millions $) 0
  Capital Exp. (TTM) (Millions $) -1





  Ratio
   Capital Ratio (MRQ) 0.56
  Total Debt to Equity (MRQ) -
  Tangible Leverage Ratio (MRQ) -
  Asset Turnover Ratio (TTM) -
  Inventory Turnover Ratio (TTM) -





Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com